JPMorgan has launched a healthcare venture capital practice, entering the market at a time when innovation in the life sciences remains high but investment has pulled back from last year’s record pace.

The largest US bank by assets has created a venture team targeting the life sciences through JPMorgan Private Capital, a growth-equity and private-credit investment group within JPMorgan Asset Management.